Die chronische Niereninsuffizienz – Wie sieht ein effektives Management aus?

Eine der häufigsten Krankheiten bei älteren Katzen ist die chronische Niereninsuffizienz mit einer Prävalenz von ca. 10 %. Besonders problematisch ist, dass die Symptome der Erkrankung aufgrund ihres schleichenden Verlaufs von den Tierbesitzern oft nicht als Krankheitszeichen wahrgenommen werden. Grundlagen für ein effektives Management der chronischen Niereninsuffizienz sind die regelmäßige Kontrolle des klinischen Zustandes des Patienten sowie der entsprechenden Laborparameter.

• Literatur

• 1 Barber PJ, Rawlings JM, Markwell PJ et al Effect of dietary phosphate restriction on secondary renal hyperparathyreoidism in the cat. J Small Anim Pract 1999; 40: 62-70
• 2 Barber P, Elliot J. Feline chronic renal failure: calcium homeostasis in 80 cases diagnosed between 1992 and 1995. J Small Anim Pract 1998; 39: 108-116
• 3 Bro S, Olgaard K. Effects of excess PTH on nonclassical target organs. Am J Kidney Dis 1997; 30: 606-620
• 4 Chew DJ. The role of phosphorus in feline chronic renal disease, ESFM Feline Congress 2008. Edinburgh: Scientific Proceedings; 2008: 59-65
• 5 Cowgill L et al Use of recombinant human erythropoietin for management of anemia in dogs and cats with renal failure. J Am Vet Med Assoc 1998; 212: 521-528
• 6 Elliott J. Die azotämische Katze. Veterinary Focus 2008; 18: 8-15
• 7 Elliott J. Focus Nephrology, Feline Hyperphosphataemia and CKD. Veterinary Times; 2008: 12-16
• 8 Elliott J. The role of phosphate in chronic kidney disease (CKD) progression, Part 1. Small Animal Medicine UK Vet 2008; 13: 23-28
• 9 Elliott J. The role of phosphate in chronic kidney disease (CKD) progression, Part 2. Small Animal Medicine UK Vet 2008; 13: 37-46
• 10 Elliott J, Rawlings JM, Markwell PJ et al Survival of cats with naturally occurring renal failure: effect of conventional dietary management. J Small Anim Pract 2000; 41: 235-242
• 11 Finnah A, Höchel J, Hartmann H. Experimentelle Erprobung eines neuen renalen Funktionstests zur quantitativen Bestimmung der glomerulären Filtrationsrate (GFR) bei der Katze. Tierärztliche Praxis Kleintiere 2006; 34: 63-68
• 12 Fukagawa M, Harman C. Is Lanthanum carbonate safer and more effective than calcium carbonate for hyperphosphatemia in dialysis patients?. Nat Clin Pract Nephrol 2005; 1: 20-21
• 13 Grauer GF. Early detection of renal damage and disease in dogs and cats. Vet Clin Small Animal 2005; 35: 581-596
• 14 Heine R. Labordiagnostik bei felinen Nierenerkrankungen. Veterinary Focus 2008; 18: 16-22
• 15 Kuwahara Y, Ohba Y, Kitoh K et al Association of laboratory data and death within one month in cats with chronic renal failure. J Small Anim Pract 2006; 47: 446-450
• 16 Lulich JP, Osborne CA, O'Brien TD et al Feline renal failure: Questions, answers, questions. Compend Contin Educ Pract Vet 1992; 14: 127-152
• 17 Lund EM, Armstrong PJ, Kirk CA et al Health status and population characteristics of dogs and cats examined at private veterinary practices in the United States. J Am Vet Med Assoc 1999; 214: 1336-1341
• 18 Mayer-Roenne B, Goldstein RE, Erb HN. Urinary tract infections in cats with hyperthyroidism, diabetes mellitus and chronic kidney disease. J Feline Med Surg 2007; 9: 124-134
• 19 Neiger R. Krankheiten der Niere und der ableitenden Harnwege. In: Horzinek M, Schmidt V, Lutz H, Hrsg. Krankheiten der Katze. Stuttgart: Enke Verlag; 2005: 403
• 20 Plantinga EA, Everts H, Kastelein AMC et al Retrospective study of the survival of cats with acquired chronic renal insufficiency offered different commercial diets. The Veterinary Record 2005; 156: 185-187
• 21 Polzin DJ, Osbourne CA, Adams LG et al Medical management of feline chronic renal failure. In: Bonagura JD, Kirk RW, eds. Current Veterinary Therapy X1. Philadelphia, PA: Saunders; 1992: 848-853
• 22 Polzin DJ, Osborne CA, Ross S. Chronic kidney disease. In: Ettinger ST, Feldmann EC. Textbook of Veterinary Internal Medicine. St. Louis: Elsevier Saunders; 2005: 1756-1784
• 23 Rubin SI. Chronic renal failure and its management and nephrolithiasis. Vet Clin Small Anim 1997; 27: 1331-1354
• 24 Schmidt B, Delport P, Spiecker-Hauser U. Bay 78–1887, a novel lanthanum-based phosphate binder, decreases intestinal phosphorus absorption in cats. J Vet Pharmacol Therap 2006; 29 (Suppl. 01) 206-207
• 25 Schmidt B, Adler K, Hellmann K. The use of Renalzin, a new intestinal phosphate binder, in feline chronic renal failure. Proceedings of the Vetoalp 2008 Conference. France: March 2008: 69
• 26 Schmidt B, Spiecker-Hauser U, Gropp J. Effect of Lantharenol® on apparent phosphorus absorption from a conventional feline maintenance diet and a renal diet for cats. Proc Soc Nutr Physiol; 2008: 17 (in press)
• 27 Schmidt B, Spiecker-Hauser U, Murphy M. Efficacy and safety of lantharenol® on phosphorus metabolism in cats with chronic kidney disease. J Vet Intern Med 2008; 22: 798
• 28 Spiecker-Hauser U, Kraemer F, Epe C et al Efficacy of Lantharenol to reduce intestinal phosphorus absorption from feline renal diet. 11th Congress of the European Society of Veterinary and Comparative Nutrition. Leipzig: 2007: 133
• 29 Sturgess K. Nutritional management of Renal Disease, Proceedings of the 33rd WSAVA/FECAVA Congress. Dublin: 2008: 281-284
• 30 Syme HM, Markwel PJ, Pfeiffer D et al Survival of cats with naturally occurring chronic renal failure is related to severity of proteinuria. J Vet Intern Med 2006; 20: 528-535
• 31 Watson AD. Indicators of renal insufficiency in dogs and cats presented at a veterinary teaching hospital. Aust Vet Practit 2001; 31: 54-58
• 32 Wolf AM. Chronic Progressive Renal Disease in the Cat: Recognition and Management, North American Veterinary Conference Orlando, NAVC Proceedings, Vol. 20 small animal editon. 2006: 701-703